Patented small molecule inhibitors of HIV-1 integrase: a 10-year saga

Bibliography

• BILLICH A, SCHAUER M, FRANKS, ROSENWIRTH B, BILLICH S: HIV-1 integrase: high-level production and screening assay for the endonucleolytic activity. Antiviral Chem. Chemother. (1992) 3:113–119.
   Web of Science ®Google Scholar
• YOSHINAGA T, SATO A, FUJISHITA T, FUJIWARA T: In vitro activity of a New HIV-1 Integrase Inhibitor in Clinical Development. 9th Conference on Retroviruses and Opportunistic Infections. Seattle, USA (2002).
   Google Scholar
• NEAMATI N, BARCHI Jr., JJ: New paradigms in drug design and discovery. Curr. Topics Med. Chem. (2002) 2:211–227.
   PubMedGoogle Scholar
• HAZUDA DJ, HASTINGS JC, WOLFE AL, EMINI EA: A novel assay for the DNA strand-transfer reaction of HIV-1 integrase. Nucleic Acid Res. (1994) 22:1121–1122.
   PubMed Web of Science ®Google Scholar
• MAZUMDER A, NEAMATI N, SUNDER S, OWEN J, POMMIER Y: Retroviral integrase: a novel target in antiviral development; basic in vitro assays with the purified enzyme. In: Methods in Cellular and Molecular Biology Antiviral Evaluation. The Humana Press, Inc., Totowa, NJ, USA (1999).
   Google Scholar
• CHOW SA: In vitro assays for activities of retroviral integrase. Methods (1997) 12:306–317.
   PubMed Web of Science ®Google Scholar
• MARCHAND C, NEAMATI N, POMMIER Y: In vitro human immunodeficiency virus Type 1 integrase assays. Methods Enzymol. (2001) 340:624–633.
   PubMed Web of Science ®Google Scholar
• DEBYSER Z, CHEREPANOV E PLUYMERS W, DE CLERCQ E: Assays for the evaluation of HIV-1 integrase inhibitors. Methods Mal Biol. (2001) 160:139–155.
   PubMedGoogle Scholar
• HAZUDA DJ, FELOCK P, WITMER M,WOLFE A, STILLMOCK K et al: Inhibitors of strand transfer that prevent integration and inhibit HIV- 1 replication in cells. Science (2000) 287:646–650.
   PubMed Web of Science ®Google Scholar
• FARNET CM, BUSHMAN FD: HIV cDNA integration: molecular biology and inhibitor development. AIDS (1996) 10:S3–11.
   Web of Science ®Google Scholar
• ASANTE-APPIAH E, SKALKA A: M. Molecular mechanisms in retrovirus DNA integration. Antiviral Res. (1997) 36:139–156.
   PubMed Web of Science ®Google Scholar
• POMMIER Y, PILON A, BAJAJ K, MAZUMDER A, NEAMATI N: HIV-1 integrase as a target for antiviral drugs. Antiviral Chem. Chemother. (1997) 8:463–483.
   Web of Science ®Google Scholar
• NEAMATI N, SUNDERS, POMMIER Y:Design and discovery of HIV-1 integrase inhibitors. Drug Discovery Today (1997) 2:487–498.
   Web of Science ®Google Scholar
• •A comprehensive review of integrase inhibitors with numerous structures.
   Google Scholar
• HANSEN MS, CARTEAU S, HOFFMANN C, LI L, BUSHMAN F: Retroviral cDNA integration: mechanism, applications and inhibition. Genet. Eng. (1998) 20:41–61.
   Google Scholar
• ROBINSON JW: HIV integrase: the nexttarget? Infect. Med. (1998) 15:129–137.
   Web of Science ®Google Scholar
• NEAMATI N, MARCHAND C, POMMIER Y: HIV-1 integrase inhibitors: past, present, and future. Adv. Pharmacol (2000) 49:147–165.
   PubMedGoogle Scholar
• •A good review on the chemistry of retroviral integrases and reported mutations.
   Google Scholar
• POMMIER Y, NEAMATI N: Inhibitors of human immunodeficiency virus integrase. Adv. Virus Res. (1999) 52:427–458.
   PubMed Web of Science ®Google Scholar
• POMMIER Y, MARCHAND C, NEAMATI N: Retroviral integrase inhibitors year (2000): update and perspectives. Antiviral Res. (2000) 47:139–148.
   PubMed Web of Science ®Google Scholar
• PANI A, MARONGIU ME: Anti-HIV-1 integrase drugs: how far from the shelf? Cum: Pharm. Des. (2000) 6:569–584.
   Google Scholar
• NEAMATI N: Structure-based HIV-1 integrase inhibitor design: a future perspective. Expert Opirt. Investig. Drugs (2001) 10(2):281–296.
   PubMed Web of Science ®Google Scholar
• D'ANGELO J, MOUSCADET JF, DESMAELE D, ZOUHIRI E LEH H: HIV-1 integrase: the next target for AIDS therapy? Pathol Biol. Paris (2031) 49:237–246.
   Google Scholar
• LIN Z, NEAMATI N, ZHAO H etal.: Chicoric acid analogues as HIV-1 integrase inhibitors. j Med. Chem. (1999) 42:1401–1414.
   Google Scholar
• PLUYMERS W, NEAMATI N, PANNECOUQUE C etal.: Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters. Mal Pharmacol (2000) 58:641–648.
   Google Scholar
• FESEN MR, KOHN KW, LETEURTRE F, POMMIER Y: Inhibitors of human immunodeficiency virus integrase. Proc. Natl. Acad Sci. USA (1993) 90:2399–2403.
   PubMed Web of Science ®Google Scholar
• NEAMATI N, MAZUMDER A, SUNDER S et al.: Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus Type 1 integrase. Mal Pharmacol (1998) 54:280–290.
   PubMed Web of Science ®Google Scholar
• LAFEMINA RL, GRAHAM PL, LEGROW K etal.: Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrob. Agents Chemother. (1995) 39:320–324.
   Google Scholar
• FESEN MR, POMMIER Y, LETEURTRE F et al.: Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochem. Pharmacol (1994) 48:595–608.
   PubMed Web of Science ®Google Scholar
• MAZUMDER A, RAGHAVAN K, WEINSTEIN J, KOHN KW, POMMIER Y: Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem. Pharmacol (1995) 49:1165–1170.
   PubMed Web of Science ®Google Scholar
• ZHAO H, NEAMATI N, MAZUMDER A etal.: Arylamide inhibitors of HIV-1 integrase.j Med. Chem. (1997) 40:1186–1194.
   Google Scholar
• NEAMATI N, MAZUMDER A, ZHAO H et al: Diarylsulfones, a novel class of human immunodeficiency virus Type 1 integrase inhibitors. Antimicrob. Agents Chemother. (1997) 41:385–393.
   PubMed Web of Science ®Google Scholar
• NEAMATI N, HONG H, SUNDER S, MILNE GW, POMMIER Y: Potent inhibitors of human immunodeficiency virus Type 1 integrase: identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors. Mal Pharmacol (1997) 52:1041–1055.
   PubMed Web of Science ®Google Scholar
• MEKOUAR K, MOUSCADET JF, DESMAELE D et al: Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells. j Med. Chem. (1998) 41:2846–2857.
   PubMed Web of Science ®Google Scholar
• STAN WELL C, YE B, YUSPA SH, BURKE TR Jr: Cell protein cross-linking by erbstatin and related compounds. Biochem. Pharmacol (1996) 52:475–480.
   PubMed Web of Science ®Google Scholar
• NEAMATI N, HONG H, MAZUMDER A: Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. Med. Chem. (1997) 40:942–951.
   Web of Science ®Google Scholar
• NEAMATI N, HONG H, OWEN JM et al.: Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site. j Med. Chem. (1998) 41:3202–3209.
   PubMedGoogle Scholar
• ZHAO H, NEAMATI N, SUNDER S et al.: Hydrazide-containing inhibitors of HIV-1 integrase. I Med. Chem. (1997) 40:937–941.
   PubMed Web of Science ®Google Scholar
• NEAMATI N, TURPIN JA, WINSLOW HE etal.: Thiazolothiazepine inhibitors of HIV-1 integrase. I Med. Chem. (1999) 42:3334–3341.
   Google Scholar
• ZHAO H, NEAMATI N, HONG H etal.: Coumarin-based inhibitors of HIV integrase. Med. Chem. (1997) 40:242–249.
   Google Scholar
• MAZUMDER A, WANG S, NEAMATI N et al.: Antiretroviral agents as inhibitors of both human immunodeficiency virusType 1 integrase and protease. I Med. Chem. (1996) 39:2472–2481.
   PubMed Web of Science ®Google Scholar
• GOLDGURY, CRAIGIE R, COHEN GH et al.: Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc. Natl. Acad. Sci. USA (1999) 96:13040–13043.
   PubMed Web of Science ®Google Scholar
• MAZUMDER A, NEAMATI N, SUNDER S et al.: Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. Med. Chem. (1997) 40:3057–3063.
   Web of Science ®Google Scholar
• MELEK M, JONES JM, O'DEA MH et al.: Effect of HIV integrase inhibitors on the RAG1/2 recombinase. Proc. Nati Acad. Sci. USA (2002) 99:134–137.
   Google Scholar
• ••The first report of inhibition of the RAG1/2system by diketoacid integrase inhibitors.
   Google Scholar